Novartis has acquired AveXis
In April this year, we heard that talks were ongoing regarding a proposed acquisition of AveXis by Novartis. We have now been informed that this has happened so as that AveXis is now officially a Novartis company.
AveXis has provided us with a community update, stating that the company remains steadfastly dedicated to the SMA community. They are excited about the promise of the future as a part of this organisation and hope to accelerate their mission of bringing AVXS‐101 to people with SMA as quickly and safely as possible.